⌘K

Login Start Free

Home/Filings/4/0001104659-21-123265

4//SEC Filing

FROM STEPHEN 4

Accession 0001104659-21-123265

CIK 0001372514other

View on SEC.gov Company Profile

Filed

Oct 4, 8:00 PM ET

Accepted

Oct 5, 6:39 PM ET

Size

4.7 KB

Accession

0001104659-21-123265

Insider Transaction Report

Form 4

Period: 2021-10-04

EYEGATE PHARMACEUTICALS INCEYEG

DirectorPresident and CEO

Transactions

Tax Payment
Common Stock
2021-10-04$2.01/sh−249$500→ 68,542 total

Footnotes (1)

[F1]Sale of shares to cover taxes due on restricted stock that vested on 10/01/2021.

Documents

1 file

4
tm2129310d1_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

EYEGATE PHARMACEUTICALS INC

CIK 0001372514

Entity typeother

Related Parties

1

filerCIK 0001620137

Filing Metadata

Form type: 4
Filed: Oct 4, 8:00 PM ET
Accepted: Oct 5, 6:39 PM ET
Size: 4.7 KB

View on SEC.gov